Biodesix Inc
BDSX0.310USD
+0.007+2.58%
Cierre 06/02, 16:00（ET）Cotizaciones retrasadas 15 min
45.37MCap. mercado
PérdidaP/E TTM
Más Datos de Biodesix Inc Compañía
Biodesix, Inc. is a diagnostic solutions company. Biodesix Diagnostic Tests, marketed as Nodify Lung Nodule Risk Assessment and IQLung Cancer Treatment Guidance, support clinical decisions to expedite personalized care and improve outcomes for patients with lung disease. Biodesix Development Services enable biopharmaceutical, life sciences, and research institutions with scientific, technological, and operational capabilities that fuel the development of diagnostic tests, tools, and therapeutics. The Nodify Lung Nodule Risk Assessment assesses a suspicious lung nodule's risk of lung cancer to help identify the most appropriate treatment pathway. Nodify CDT and Nodify XL2 tests are marketed as Nodify Lung Nodule Risk Assessment. The Nodify CDT test is a blood-based test that detects the presence of seven autoantibodies associated with the presence of tumors. GeneStrat ddPCR, GeneStrat NGS and VeriStrat tests are marketed as part of its IQLung testing strategy.
Información de la empresa
Código de la empresaBDSX
Nombre de la empresaBiodesix Inc
Fecha de salida a bolsaOct 28, 2020
Fundada en2005
Director ejecutivoMr. Scott Hutton
Número de empleados273
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 28
Dirección919 West Dillon Road
CiudadLOUISVILLE
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal80027
Teléfono13034170500
Sitio Webhttps://www.biodesix.com/
Código de la empresaBDSX
Fecha de salida a bolsaOct 28, 2020
Fundada en2005
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John Patience
Mr. John Patience
Independent Chairman of the Board
Independent Chairman of the Board
7.42M
+1.26%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
3.06M
--
Dr. Jon Faiz Kayyem, Ph.D.
Dr. Jon Faiz Kayyem, Ph.D.
Independent Director
Independent Director
357.54K
--
Mr. Hany Massarany
Mr. Hany Massarany
Independent Director
Independent Director
337.13K
+0.81%
Ms. Robin Harper Cowie
Ms. Robin Harper Cowie
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
248.63K
+0.88%
Mr. Kieran O'Kane
Mr. Kieran O'Kane
Chief Commercial Officer
Chief Commercial Officer
139.05K
+0.73%
Ms. Jean M. Franchi, CPA
Ms. Jean M. Franchi, CPA
Independent Director
Independent Director
108.14K
+32.25%
Mr. Lawrence T. (Lair) Kennedy, Jr.
Mr. Lawrence T. (Lair) Kennedy, Jr.
Independent Director
Independent Director
--
--
Mr. Scott Hutton
Mr. Scott Hutton
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. John Patience
Mr. John Patience
Independent Chairman of the Board
Independent Chairman of the Board
7.42M
+1.26%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
3.06M
--
Dr. Jon Faiz Kayyem, Ph.D.
Dr. Jon Faiz Kayyem, Ph.D.
Independent Director
Independent Director
357.54K
--
Mr. Hany Massarany
Mr. Hany Massarany
Independent Director
Independent Director
337.13K
+0.81%
Ms. Robin Harper Cowie
Ms. Robin Harper Cowie
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
248.63K
+0.88%
Mr. Kieran O'Kane
Mr. Kieran O'Kane
Chief Commercial Officer
Chief Commercial Officer
139.05K
+0.73%
Desglose de ingresos
Divisa: USDHora de actualización: dom., 6 de abr
Divisa: USDHora de actualización: dom., 6 de abr
FY2024
Por negocioUSD
Nombre
Ganancia
Proporción
Lung Diagnostic Testing
64.71M
90.73%
Development Services
6.62M
9.27%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Lung Diagnostic Testing
64.71M
90.73%
Development Services
6.62M
9.27%
Accionista
Hora de actualización: jue., 15 de may
Hora de actualización: jue., 15 de may
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
Schuler (Jack W)
24.51%
Kennedy (Lawrence T Jr.)
17.37%
Telemark Asset Management, LLC
5.65%
Patience (John)
5.07%
Bryn Mawr Trust Company
4.16%
Other
43.25%
Estadísticas de accionistas
Accionista
Proporción
Schuler (Jack W)
24.51%
Kennedy (Lawrence T Jr.)
17.37%
Telemark Asset Management, LLC
5.65%
Patience (John)
5.07%
Bryn Mawr Trust Company
4.16%
Other
43.25%
Tipo
Accionista
Proporción
Individual Investor
50.74%
Investment Advisor
11.75%
Hedge Fund
9.83%
Investment Advisor/Hedge Fund
6.18%
Bank and Trust
4.16%
Private Equity
3.67%
Corporation
1.49%
Research Firm
0.79%
Venture Capital
0.07%
Other
11.31%
Participación institucional
Hora de actualización: sáb., 22 de feb
Hora de actualización: sáb., 22 de feb
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
114
128.07M
87.48%
-971.92K
2024Q4
117
129.55M
88.77%
+1.50M
2024Q3
108
133.06M
91.48%
+18.48M
2024Q2
113
122.73M
87.79%
+36.49M
2024Q1
129
78.49M
81.85%
-3.28M
2023Q4
126
82.91M
102.14%
+18.03M
2023Q3
132
83.04M
103.87%
+18.19M
2023Q2
137
65.80M
84.63%
+503.77K
2023Q1
140
65.48M
84.42%
+858.57K
2022Q4
144
63.63M
87.33%
+26.33M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Schuler (Jack W)
30.79M
21.1%
+86.96K
+0.28%
May 23, 2024
Kennedy (Lawrence T Jr.)
25.35M
17.36%
+4.35M
+20.70%
May 21, 2024
Telemark Asset Management, LLC
8.28M
5.67%
--
--
Dec 31, 2024
Patience (John)
7.38M
5.05%
+46.69K
+0.64%
Mar 31, 2025
Bryn Mawr Trust Company
6.10M
4.18%
--
--
Dec 31, 2024
Birchview Capital, LP
5.58M
3.82%
+40.00K
+0.72%
Dec 31, 2024
SilverArc Capital Management, LLC
4.33M
2.97%
+771.19K
+21.66%
Dec 31, 2024
Monashee Investment Management, LLC
3.50M
2.4%
--
--
Dec 31, 2024
The Vanguard Group, Inc.
3.82M
2.62%
+861.00K
+29.06%
Dec 31, 2024
Opaleye Management Inc.
3.46M
2.37%
-350.00K
-9.17%
Dec 31, 2024
Ver más
ETFs relacionados
Hora de actualización: lun., 2 de jun
Hora de actualización: lun., 2 de jun
Nombre
Proporción
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proporción0%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
